A detailed history of Old National Bancorp transactions in Astrazeneca PLC stock. As of the latest transaction made, Old National Bancorp holds 8,266 shares of AZN stock, worth $658,882. This represents 0.02% of its overall portfolio holdings.

Number of Shares
8,266
Previous 9,805 15.7%
Holding current value
$658,882
Previous $664,000 3.01%
% of portfolio
0.02%
Previous 0.02%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

SELL
$66.81 - $80.83 $102,820 - $124,397
-1,539 Reduced 15.7%
8,266 $644,000
Q1 2024

Apr 15, 2024

SELL
$61.03 - $69.57 $101,187 - $115,347
-1,658 Reduced 14.46%
9,805 $664,000
Q4 2023

Feb 01, 2024

BUY
$61.89 - $69.28 $130,773 - $146,388
2,113 Added 22.6%
11,463 $772,000
Q3 2023

Nov 17, 2023

BUY
$64.85 - $71.7 $16,796 - $18,570
259 Added 2.85%
9,350 $633,000
Q2 2023

Jul 25, 2023

SELL
$69.91 - $75.81 $446,794 - $484,501
-6,391 Reduced 41.28%
9,091 $650,000
Q1 2023

Apr 19, 2023

SELL
$63.15 - $71.6 $61,760 - $70,024
-978 Reduced 5.94%
15,482 $1.07 Million
Q4 2022

Feb 03, 2023

BUY
$54.21 - $70.44 $93,186 - $121,086
1,719 Added 11.66%
16,460 $1.12 Million
Q3 2022

Feb 17, 2023

SELL
$53.02 - $135.75 $91,141 - $233,354
-1,719 Reduced 10.44%
14,741 $809,000
Q3 2022

Nov 08, 2022

BUY
$53.02 - $135.75 $146,918 - $376,163
2,771 Added 23.15%
14,741 $809,000
Q2 2022

Jul 25, 2022

BUY
$59.26 - $71.14 $396,627 - $476,140
6,693 Added 126.83%
11,970 $790,000
Q1 2022

May 09, 2022

SELL
$55.72 - $67.12 $724 - $872
-13 Reduced 0.25%
5,277 $350,000
Q4 2021

Jan 25, 2022

BUY
$54.02 - $63.83 $10,695 - $12,638
198 Added 3.89%
5,290 $308,000
Q2 2021

Jul 26, 2021

BUY
$48.42 - $60.18 $246,554 - $306,436
5,092 New
5,092 $305,000

Others Institutions Holding AZN

About ASTRAZENECA PLC


  • Ticker AZN
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 3,099,020,032
  • Market Cap $247B
  • Description
  • AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...
More about AZN
Track This Portfolio

Track Old National Bancorp Portfolio

Follow Old National Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

News

Stay updated on Old National Bancorp with notifications on news.